Colorectal cancer: NICE issues an updated quality standard

  • NICE

  • curated by Pavankumar Kamat
  • UK Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

The National Institute for Health and Care Excellence (NICE) has issued an updated quality standard focusing on the management of local and metastatic disease in adults (aged ≥18 years) with colorectal (bowel) cancer.

The key goals of the quality standard are improvements in the following areas:

  • Premature mortality;
  • Quality of life for individuals with long-term conditions;
  • Recovery from episodes of ill health or after injury;
  • Patient experience of care;
  • Safe environment for treatment and care and avoidance of harm.

The quality standard covers the following three recommendations:

  1. Individuals with rectal cancer should be offered a preoperative treatment strategy based on their stage of local disease recurrence.
  2. For individuals with colorectal cancer metastasised in the liver, a hepatobiliary multidisciplinary team should review their scans and determine the requirement for further imaging to confirm suitability for local treatment.
  3. Individuals who are disease-free after treatment for colorectal cancer should be offered regular surveillance.

Health professionals should also consider the quality standard on Suspected cancer, Patient experience in adult NHS services and End of life care for adults when providing services for colorectal cancer.